期刊文献+

TIPS术治疗门静脉高压症的进展与展望 被引量:1

Progress and prospect of TIPS for portal hypertension
原文传递
导出
摘要 经颈静脉肝内门体分流术治疗肝硬化门静脉高压已经有30多年的历史,随着支架技术及临床实践技术的发展,经颈静脉肝内门体分流术治疗门静脉高压症技术日臻完善。从过去单一使用裸支架到裸支架联合覆膜支架应用或专用Viatorr支架术式,支架通畅性得到了显著提高。此外通过支架口径的选择、分流道穿刺部分的选择等,逐渐减少了因为分流过大引起的肝性脑病、肝功能衰竭等并发症的发生。经颈静脉肝内门体分流术技术具有微创、安全、降低门静脉压力的确切优点,在治疗门静脉高压症食管胃静脉曲张出血、顽固性腹水等方面逐渐成为主要的手术方式之一。 Transjugular intrahepatic portosystemic shunt(TIPS)has been used in the treatment of cirrhotic portal hypertension for more than 30 years.With the development of stent technology and clinical practice technology,TIPS is becoming more and more perfect in the treatment of portal hypertension.From the single-use of bare stent in the past to the application of bare stent combined with coated stent or particular Viatorr stent,the patency of stent has been significantly improved.In addition,the selection of stent caliber and the puncture part of shunt gradually reduces the occurrence of hepatic encephalopathy,liver failure and other complications caused by excessive shunt.TIPS technology has the advantages of minimally invasive,safe and reducing portal vein pressure.It has gradually become one of the primary surgical methods in the treatment of portal hypertension,esophagogastric variceal bleeding,intractable ascites,and so on.
作者 马军 MA Jun(Department of Interventional and Vascular Surgery,The People’s Hospital of Ningxia Hui Autonomous Region,Yinchuan 750002,P.R.China)
出处 《中国普外基础与临床杂志》 CAS 2022年第8期997-1000,共4页 Chinese Journal of Bases and Clinics In General Surgery
关键词 门静脉高压症 食管胃底静脉曲张破裂出血 经颈静脉肝内门体分流术 进展 portal hypertension esophagogastric variceal bleeding transjugular intrahepatic portosystemic shunt progress
  • 相关文献

参考文献11

二级参考文献72

  • 1李继先,宗修锟,关治礼,刘永诚,陆立,毕景明,李铁,穆景龙,郭福义,王玉国.门静脉高压与非门静脉高压患者外周及腹内主要静脉血氨的对比观察[J].中华外科杂志,1996,34(8):511-511. 被引量:9
  • 2李继先 郭福义 等.成人外周血门静脉肠系膜上静脉血氨值及其在门脉高压症分流术中的意义[J].中华外科杂志,1990,28:310-310.
  • 3Lauermann J, Potthoff A, Mc Cavert M, et al. Comparison of Technical and Clinical Outcome of Transjugular Portosystemic Shunt Placement Between a Bare Metal Stent and a PTFE-Stent- graft Device [ J ]. Cardiovasc Intervent Radiol, 2016,39 (4) : 547- 556. DOI : 10. 1007/s00270-015-1209-x.
  • 4Citron SJ. Re: "Portal Vein Recanalization-Transjugular Intrahe- patic Portosystemic Shunt Using the Transsplenic Approach to Achieve Transplant Candidacy in Patients with Chronic Portal Vein Thrombosis" [J].J Vasc Interv Radiol, 2015,26 ( 11 ) : 1750. DOI:10. 1016/j. jvir. 2015.07. 015.
  • 5Salem R, Vouche M, Baker T, et al. Pretransplant Portal Vein Recanalization-Transjugular Intrahepatic Portosystemic Shunt in Patients With Complete Obliterative Portal Vein Thrombosis [ J ]. Transplantation,2015,99 ( 11 ) : 2347-2355. DOI: 10. 1097/TP. 0000000000000729.
  • 6Gaba RC, Omene BO, Podczerwinski ES, et al. TIPS for treat- ment of variceal hemorrhage: clinical outcomes in 128 patients at a single institution over a 12-year period[J]. J Vasc Interv Radiol, 2012,23(2) :227~235. DOI:10. 1016/j. jvir. 2011.10.015.
  • 7Garcia-Pagrn JC, Caca K, Bureau C, et al. Early use of TIPS in patients with cirrhosis and variceal bleeding [ J ]. N Engl J Med, 2010,362 ( 25 ) : 2370-2379. DOI : 10. 1056/NEJMoa0910102.
  • 8de Franchis R; Baveno IV Faculty. Expanding consensus in portal hypertension: Report of the Baveno IV Consensus Workshop: Stratifying risk and individualizing care for portal hypertension [ J ]. J Hepatol, 2015,63 ( 3 ) : 743-752. DOI : 10. 1016/j. jhep. 2015. 05. 022.
  • 9Petersen BD, Clark TW. Direct intrahepatie portocaval shunt[ J]. Tech Vasc Interv Radiol,2008,11 (4) :230-234. DOI:I0. 1053/ j. tvir. 2009.04. 006.
  • 10RCissle M. Root Cause Analysis: Can It Improve Outcome after Transjugular Intrahepatic Portosystemic Shunt Creation? [J]. J Vasc Interv Radiol,2015,26 (10) : 1453-1455. DOI: 10. 1016/j. jvir. 2015.07. 030.

共引文献514

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部